Pulse Oximeter Market Report 2025

The pulse oximeter market size has grown steadily in recent years. It will grow from $2.64 billion in 2024 to $2.75 billion in 2025 at a compound annual growth rate (CAGR) of 4.3%. The growth in the historic period can be attributed to the increasing aging population, rise in respiratory diseases, hospital and healthcare infrastructure development, awareness and education, and global pandemic impact.

The pulse oximeter market size is expected to see strong growth in the next few years. It will grow to $3.54 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to integration with wearable devices, global health crises preparedness, government healthcare initiatives, health and wellness monitoring, and global health crises preparedness. Major trends in the forecast period include telehealth integration, technological advancements, home healthcare emphasis, smart features and connectivity, and remote patient monitoring in chronic diseases.

The rising prevalence of respiratory diseases is projected to drive growth in the pulse oximeter market in the future. Respiratory diseases are conditions affecting the airways and lungs, which impact human respiration. This increase is largely attributed to factors such as growing air pollution, dust exposure, an aging population, and smoking habits. Pulse oximeters are valuable in detecting changes in oxygen saturation levels before symptoms become noticeable. For example, in December 2023, the National Center for Biotechnology Information, a US-based government agency, reported that cases of COPD are expected to rise by 112 million, reaching a total of 592 million by 2050, representing 9.5% of the eligible population. Consequently, the growing prevalence of respiratory diseases is driving the demand for pulse oximeters.

The growing expansion of telehealth and telemedicine is expected to drive the growth of the pulse oximeter market in the future. Telehealth encompasses the use of telecommunications technology to deliver a variety of healthcare services and information remotely, while telemedicine specifically refers to remote clinical consultations and healthcare delivery. Pulse oximeters play a vital role in assessing oxygen levels from a distance, which is particularly important for at-home healthcare, especially for patients with chronic conditions. The integration of pulse oximeters with wearables and smartphones enhances their utility in telehealth, enabling seamless data sharing. This integration reduces the necessity for hospital visits, as patients can use pulse oximeters at home to transmit real-time data for remote evaluation. For instance, in June 2024, the Centers for Disease Control and Prevention, a US-based government agency, reported that in 2022, 30.1% of adults had used telemedicine in the past year. Therefore, the increasing expansion of telehealth and telemedicine is driving the growth of the pulse oximeter market.

Major companies in the pulse oximeter market are concentrating on developing technologically advanced solutions, such as cellular-connected pulse oximeters, to improve patient monitoring and data collection. A cellular-connected pulse oximeter is equipped with cellular connectivity features, enabling it to transmit data wirelessly over cellular networks (like 4G or 5G) to healthcare providers or cloud-based health platforms. For example, in August 2024, Prevounce Health LLC, a US-based developer of a remote monitoring platform, launched the Pylo OX1-LTE, a cellular-connected pulse oximeter specifically designed for remote patient monitoring (RPM). Aimed at patients with chronic respiratory conditions such as COPD and asthma, as well as those impacted by COVID-19, the device offers reliable cellular connectivity, accurate SpO2 and pulse rate readings, and a user-friendly design with a bright OLED screen. It integrates seamlessly with Prevounce's remote care management platform and can connect to third-party health software via the Pylo cloud API.

Prominent companies in the pulse oximeter market are actively investing in cutting-edge technologies, such as Pulse Oximetry (SpO2) Sensor Technology, to gain a competitive edge. Pulse Oximetry (SpO2) Sensor Technology employs specialized sensors to measure oxygen saturation levels in the blood, commonly expressed as SpO2. In November 2022, BioIntelliSense Inc., a US-based patient monitoring solutions company, introduced innovative pulse oximetry (SpO2) sensor technology addressing challenges related to skin pigmentation and motion monitoring. This patented sensor chipset and integrated processing technology ensure medical-grade accuracy, even across diverse skin tones and during movement. This breakthrough technology aims to contribute to healthcare equity by overcoming historical accuracy issues during activity and with darker skin tones. The design incorporates a unique white light emitter and spectral sensor, surpassing traditional architectures and providing clinically accurate SpO2 measurements.

In January 2022, ICU Medical, a US-based specialist in infusion therapy and critical care, completed the acquisition of Smiths Medical for an undisclosed amount. This strategic move enables ICU Medical to expand its product line with Smiths Medical's offerings, including infusion pumps, catheters, and various vascular access equipment. Smiths Medical, a US-based company specializing in innovative medical products, including pulse oximeters, adds valuable diversity to ICU Medical's portfolio through this acquisition.

Major companies operating in the pulse oximeter market include Medtronic Plc, GE Healthcare, Masimo Corporation, Nonin Medical Inc., Nihon Kohden Corporation, Koninklijke Philips NV, Philips Healthcare, Contec Medical Systems Co. Ltd., Omron Corporation, Carefusion Corp., CAS Medical Systems Inc., Opto Circuits India Ltd., Welch Allyn Inc., Spacelabs Healthcare, Meditech Equipment Co. Ltd., Vyaire Medical Inc., Beurer GmbH, Drägerwerk AG & Co. KGaA, ICU Medical Inc., Smiths Medical, Mindray Medical International Limited, Criticare Systems Inc., BPL Medical Technologies, ChoiceMMed America Co. Ltd., Beijing Choice Electronic Technology Co. Ltd., Creative Medical, Edan Instruments Inc., Heal Force Bio-Meditech Holdings Limited, Mediana Co. Ltd., Medlab Clinical Ltd.

North America was the largest region in the pulse oximeter market in 2024. The regions covered in the pulse oximeter market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pulse oximeter market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

A pulse oximeter serves as a non-invasive measurement device that promptly gauges an individual's functional oxygen saturation (SpO2), facilitating early detection of hypoxemia. The primary functionality of a pulse oximeter is to swiftly assess oxygen saturation levels in the human body without the necessity for needles or blood samples.

Diverse categories of pulse oximeters cater to specific needs, including fingertip oximeters, handheld oximeters, wrist-worn oximeters, and table-top and bedside oximeters. Fingertip oximeters, specifically, are designed for convenient attachment to a patient's fingertip, incorporating a blend of connected and conventional technologies. These devices are programmed to cater to both adult and pediatric populations. Targeted end-users encompass hospitals and clinics, ambulatory surgical centers, and home healthcare settings.

The pulse oximeters market research report is one of a series of new reports that provides pulse oximeters market statistics, including pulse oximeters industry global market size, regional shares, competitors with a pulse oximeters market share, detailed pulse oximeters market segments, market trends and opportunities, and any further data you may need to thrive in the pulse oximeters industry. This pulse oximeters market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pulse oximeter market consists of sales of finger-tip pulse oximeter, blood oxygen saturation monitor. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.